NO20080051L - Krystallinske former av 4-((2,4-diklor-5-metoksyfenyl)amino)-6-metoksy-7--[3-(4-metyl-1-piperazinyl)propoksy]3-kinolinkarbonitril og metoder for fremstilling av samme - Google Patents
Krystallinske former av 4-((2,4-diklor-5-metoksyfenyl)amino)-6-metoksy-7--[3-(4-metyl-1-piperazinyl)propoksy]3-kinolinkarbonitril og metoder for fremstilling av sammeInfo
- Publication number
- NO20080051L NO20080051L NO20080051A NO20080051A NO20080051L NO 20080051 L NO20080051 L NO 20080051L NO 20080051 A NO20080051 A NO 20080051A NO 20080051 A NO20080051 A NO 20080051A NO 20080051 L NO20080051 L NO 20080051L
- Authority
- NO
- Norway
- Prior art keywords
- piperazinyl
- methoxyphenyl
- propoxy
- dichloro
- methoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Foreliggende oppfinnelse angår et krystallinsk 4-[(2,4-diklor-5-metoksyfenyl)amino]-6-metoksy-7-[3-(4-metyl-l-piperazinyl)propoksy]-3-kinolinkarbonitril monohydrat som har et røntgen diffraksjonsmønster hvor 28 vinkler (°) for topper av betydning er omtrent: 9,19, 11,48, 14,32,19,16, 19,45, 20,46,21,29, 22,33, 23,96, 24,95,25,29, 25,84,26,55, 27,61 og 29,51 og en transisjonstemperatur på ca. 109°C til ca. 115°C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69638105P | 2005-07-01 | 2005-07-01 | |
PCT/US2006/025160 WO2007005462A1 (en) | 2005-07-01 | 2006-06-28 | Crystalline forms of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarb-onitrile and methods of preparing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080051L true NO20080051L (no) | 2008-01-29 |
Family
ID=37103295
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080051A NO20080051L (no) | 2005-07-01 | 2008-01-04 | Krystallinske former av 4-((2,4-diklor-5-metoksyfenyl)amino)-6-metoksy-7--[3-(4-metyl-1-piperazinyl)propoksy]3-kinolinkarbonitril og metoder for fremstilling av samme |
Country Status (25)
Country | Link |
---|---|
US (2) | US7767678B2 (no) |
EP (1) | EP1902029B2 (no) |
JP (1) | JP2009500332A (no) |
KR (1) | KR20080028386A (no) |
CN (1) | CN101248047A (no) |
AR (1) | AR054505A1 (no) |
AU (1) | AU2006266045A1 (no) |
BR (1) | BRPI0613574A2 (no) |
CA (1) | CA2613053C (no) |
CR (1) | CR9596A (no) |
DK (1) | DK1902029T4 (no) |
EC (1) | ECSP078063A (no) |
ES (1) | ES2449197T5 (no) |
GT (1) | GT200600282A (no) |
HK (1) | HK1114614A1 (no) |
IL (1) | IL188483A0 (no) |
MX (1) | MX2008000384A (no) |
NO (1) | NO20080051L (no) |
PA (1) | PA8685101A1 (no) |
PE (1) | PE20070190A1 (no) |
PL (1) | PL1902029T5 (no) |
PT (1) | PT1902029E (no) |
RU (1) | RU2007148072A (no) |
TW (1) | TW200740797A (no) |
WO (1) | WO2007005462A1 (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2448563A2 (en) * | 2009-07-02 | 2012-05-09 | Wyeth LLC | 3-cyanoquinoline tablet formulations and uses thereof |
WO2013187967A1 (en) | 2012-06-15 | 2013-12-19 | Institute For Cancer Research D/B/A The Research Institute Of Fox Case Cancer Center ("Fox Chase Cancer Center") | Sensitization of cancer cells to dna damage by inhibiting kinases essential for dna damage checkpoint control |
CN104447541A (zh) * | 2013-09-16 | 2015-03-25 | 天津市汉康医药生物技术有限公司 | 博舒替尼化合物 |
IN2014CH00840A (no) * | 2014-02-20 | 2015-09-18 | Apotex Inc | |
WO2015149727A1 (en) | 2014-04-02 | 2015-10-08 | Zentiva, K.S. | Novel solid phases of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1 -piperazinyl)propoxy]-3-quinolinecarbonitrile |
WO2016034150A1 (zh) * | 2014-09-04 | 2016-03-10 | 正大天晴药业集团股份有限公司 | 博舒替尼及其结晶的制备方法 |
CN105384686B (zh) * | 2014-09-04 | 2019-07-26 | 连云港润众制药有限公司 | 一种博舒替尼结晶方法 |
WO2017029584A1 (en) * | 2015-08-19 | 2017-02-23 | Sun Pharmaceutical Industries Limited | Amorphous form of bosutinib |
WO2017134679A1 (en) * | 2016-02-03 | 2017-08-10 | Msn Laboratories Private Limited | Novel crystalline polymorphs of 4-[(2.4-dichioro-5-methoxvphenvl)aniinol- 6-methoxv-7-13-(4-methyl-l-piperazinvl)propoxvl-3-quinolinecarbonitrile and process for preparation thereof |
WO2017145089A1 (en) * | 2016-02-23 | 2017-08-31 | Sun Pharmaceutical Industries Limited | Crystalline form x of bosutinib |
CN105646345A (zh) * | 2016-03-16 | 2016-06-08 | 浙江海正药业股份有限公司 | 博舒替尼的新晶型及其制备方法 |
CN106187886B (zh) * | 2016-07-06 | 2019-04-16 | 山东创新药物研发有限公司 | 一种制备高纯度伯舒替尼一水合物的方法 |
JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
CN110317168A (zh) * | 2018-03-30 | 2019-10-11 | 正大天晴药业集团股份有限公司 | 一种博舒替尼的纯化方法 |
TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Jak激酶家族之小分子抑制劑 |
WO2020209843A1 (en) | 2019-04-09 | 2020-10-15 | Massachusetts Institute Of Technology | A micro physiological model for neuronal and muscular diseases and disorders |
CN112321505B (zh) * | 2019-10-25 | 2022-08-23 | 杭州中美华东制药有限公司 | 一种伯舒替尼晶型及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
US6432979B1 (en) * | 1999-08-12 | 2002-08-13 | American Cyanamid Company | Method of treating or inhibiting colonic polyps and colorectal cancer |
UA77200C2 (en) * | 2001-08-07 | 2006-11-15 | Wyeth Corp | Antineoplastic combination of cci-779 and bkb-569 |
TWI275390B (en) * | 2002-04-30 | 2007-03-11 | Wyeth Corp | Process for the preparation of 7-substituted-3- quinolinecarbonitriles |
TW200423938A (en) * | 2003-02-21 | 2004-11-16 | Wyeth Corp | 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury |
RU2345069C2 (ru) * | 2003-08-19 | 2009-01-27 | Уайт Холдингз Корпорейшн | Способ получения 4-амино-3-хинолинкарбонитрилов |
WO2005065074A2 (en) * | 2003-09-09 | 2005-07-21 | Temple University Of The Commonwealth System Of Higher Education | Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors |
AU2003291245A1 (en) * | 2003-11-06 | 2004-06-06 | Wyeth | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) |
US7910211B2 (en) * | 2005-06-20 | 2011-03-22 | E.I. Du Pont De Nemours And Company | Process for the production of multi-layer coatings |
MX2007016542A (es) * | 2005-06-24 | 2008-03-04 | Wyeth Corp | 4-anilino-3-quinolinocarbonitrilos para el tratamiento de cancer. |
US8520232B2 (en) * | 2006-03-31 | 2013-08-27 | Konica Minolta Laboratory U.S.A., Inc. | Print job analyzing method and apparatus with print device recommendation functions |
-
2006
- 2006-06-28 BR BRPI0613574A patent/BRPI0613574A2/pt not_active IP Right Cessation
- 2006-06-28 WO PCT/US2006/025160 patent/WO2007005462A1/en active Application Filing
- 2006-06-28 CA CA2613053A patent/CA2613053C/en active Active
- 2006-06-28 MX MX2008000384A patent/MX2008000384A/es unknown
- 2006-06-28 EP EP06774184.3A patent/EP1902029B2/en active Active
- 2006-06-28 ES ES06774184T patent/ES2449197T5/es active Active
- 2006-06-28 CN CNA2006800311714A patent/CN101248047A/zh not_active Withdrawn
- 2006-06-28 RU RU2007148072/04A patent/RU2007148072A/ru not_active Application Discontinuation
- 2006-06-28 AU AU2006266045A patent/AU2006266045A1/en not_active Abandoned
- 2006-06-28 PL PL06774184.3T patent/PL1902029T5/pl unknown
- 2006-06-28 PT PT67741843T patent/PT1902029E/pt unknown
- 2006-06-28 DK DK06774184.3T patent/DK1902029T4/da active
- 2006-06-28 KR KR1020077030989A patent/KR20080028386A/ko not_active Application Discontinuation
- 2006-06-28 JP JP2008519519A patent/JP2009500332A/ja active Pending
- 2006-06-29 US US11/478,216 patent/US7767678B2/en active Active
- 2006-06-29 AR ARP060102806A patent/AR054505A1/es unknown
- 2006-06-29 GT GT200600282A patent/GT200600282A/es unknown
- 2006-06-30 PA PA20068685101A patent/PA8685101A1/es unknown
- 2006-06-30 TW TW095123896A patent/TW200740797A/zh unknown
- 2006-07-03 PE PE2006000770A patent/PE20070190A1/es not_active Application Discontinuation
-
2007
- 2007-12-17 CR CR9596A patent/CR9596A/es not_active Application Discontinuation
- 2007-12-27 IL IL188483A patent/IL188483A0/en unknown
- 2007-12-28 EC EC2007008063A patent/ECSP078063A/es unknown
-
2008
- 2008-01-04 NO NO20080051A patent/NO20080051L/no not_active Application Discontinuation
- 2008-09-12 HK HK08110155.2A patent/HK1114614A1/xx active IP Right Maintenance
-
2010
- 2010-06-22 US US12/820,306 patent/US8445496B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
PL1902029T5 (pl) | 2022-08-29 |
BRPI0613574A2 (pt) | 2016-11-16 |
WO2007005462A1 (en) | 2007-01-11 |
US20100324066A1 (en) | 2010-12-23 |
DK1902029T4 (da) | 2022-02-28 |
HK1114614A1 (en) | 2008-11-07 |
GT200600282A (es) | 2007-02-14 |
PL1902029T3 (pl) | 2014-08-29 |
DK1902029T3 (en) | 2014-02-17 |
KR20080028386A (ko) | 2008-03-31 |
AR054505A1 (es) | 2007-06-27 |
ES2449197T5 (es) | 2022-04-28 |
CR9596A (es) | 2008-03-06 |
US20070015767A1 (en) | 2007-01-18 |
CA2613053A1 (en) | 2007-01-11 |
EP1902029B1 (en) | 2014-01-08 |
US7767678B2 (en) | 2010-08-03 |
IL188483A0 (en) | 2008-04-13 |
CA2613053C (en) | 2015-11-24 |
EP1902029B2 (en) | 2022-02-16 |
TW200740797A (en) | 2007-11-01 |
CN101248047A (zh) | 2008-08-20 |
PA8685101A1 (es) | 2007-01-17 |
JP2009500332A (ja) | 2009-01-08 |
AU2006266045A1 (en) | 2007-01-11 |
RU2007148072A (ru) | 2009-08-10 |
ECSP078063A (es) | 2008-01-23 |
MX2008000384A (es) | 2008-03-07 |
US8445496B2 (en) | 2013-05-21 |
ES2449197T3 (es) | 2014-03-18 |
PT1902029E (pt) | 2014-03-05 |
PE20070190A1 (es) | 2007-03-20 |
EP1902029A1 (en) | 2008-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080051L (no) | Krystallinske former av 4-((2,4-diklor-5-metoksyfenyl)amino)-6-metoksy-7--[3-(4-metyl-1-piperazinyl)propoksy]3-kinolinkarbonitril og metoder for fremstilling av samme | |
NO20080820L (no) | Krystallinske former for 4-metyl-N-[3-(4-metylimidazol-1-yl)-5-trifluormetylfenyl]-3-(4-pyridin-3-ylpyrimidin-2-ylamino)benzamid | |
NO20076066L (no) | Oksadiazolderivater som DGAT-inhibitorer | |
NO20082481L (no) | Nye 2-aminoheterosykluser som er nyttige ved behandling av ABETA-relaterte patologier | |
NO20063501L (no) | Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese | |
NO20090755L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
MX2010006179A (es) | Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico. | |
NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
NO20082673L (no) | Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens | |
NO20090166L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
TN2009000128A1 (en) | Dihydropyridine derivatives useful as protein kinase inhibitors | |
NO20074275L (no) | 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister | |
MX2010005556A (es) | Procedimiento para la fabricacion de un derivado de indolinona. | |
NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
NO20084923L (no) | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer | |
NO20061640L (no) | Hurtig opplosningspreparat av en kalsiumreseptiraktiv forbindelse | |
NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
NO20082209L (no) | Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer | |
NO20071254L (no) | Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav. | |
NO20083065L (no) | Nye N-sulfamoylpiperidinamider for profylakse eller behandling av overvekt og beslektede tilstander | |
NO20074188L (no) | Prosess for fremstilling av montelukast og mellomprodukter for det | |
MX2011005090A (es) | Forma cristalina de un compuesto de 4-[2-(2-fluorofenoximetil)feni l] piperidina. | |
MY149058A (en) | N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275) polymorph b | |
NO20084301L (no) | Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler | |
NO20073941L (no) | Dihydroimidazotiazolderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |